Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2022 | Highlights in biliary tract and liver cancers from ESMO WCGIC 2022

Aiwu Ruth He • 5 Jul 2022
ESMO WCGIC 2022
Bile Duct Cancer Liver Cancer

Aiwu Ruth He, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA highlights several key updates in the fields of biliary tract and liver cancers from ESMO WCGIC 2022. Dr He comments on notable updates in immunotherapy and personalized therapy strategies, specifically for hepatocellular carcinoma (HCC). This interview took place at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer (ESMO WCGIC) 2022 in Barcelona, Spain.

More from Aiwu Ruth He

2:05
Future developments in immunotherapy for treatment of biliary tract cancer
Aiwu Ruth He • 5 Jul 2022
5:45
Subgroup analysis of the TOPAZ-1 study by primary tumor location
Aiwu Ruth He • 5 Jul 2022

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
0:54
Exploring durvalumab + bevacizumab + TACE in hepatocellular carcinoma: EMERALD-1 insights
Mark Yarchoan • 19 Jan 2024
The content of VJOncology is intended for healthcare professionals